Human medicinal products
SPC PL
Veterinary medicinal
products
SPC PL
Herbal medicinal products
SPC PL
Name of the medicinal
product
A B C D E F G
H I J K L M N
O P Q R S T U
V W X Y Z Å Ä Ö
Name of the medicinal
product

Marketing authorisation
holder

Marketing authorisation
number

ATC Code Codes

Free text search

Active agent

Pharmaceutical form

Adverse effect

Therapeutic indication

Contraindication

Insert text in the fields in Finnish


Summaries of Product Characteristics (SPC) for Human medicinal products

The summaries of product characteristics (SPC) contain the information relevant to the use of the medicinal products and of importance to health care professionals. The SPCs are published in Finnish; the use of Finnish key words in the search fields is therefore recommended.

Some of the medicinal products contain a condition relevant to the prescribing of the product and not always found in the SPC. The conditions for prescribing and the products covered by this condition are found in the FimeaWeb search.

The SPCs processed as part of the EU centralised marketing authorisation procedure are published by the European Medicines Agency, EMA. Fimea's service contains links to the documents on medicinal products (EPAR PI) on the EMA website. Drugs belonging to the centralised authorisation procedure can be searched in Fimea's service by using an alphabetical list or by entering the product name or ATC code.

The material being published is not necessarily complete or up-to-date due to the technical quality of files submitted to the Finnish Medicines Agency Fimea or earlier to the National Agency for Medicines and the delays in delivery. For this reason, Fimea cannot guarantee that the document on the Internet fully complies with the summary of product characteristics and package leaflet officially approved by a desicion for a marketing authorisation. Only the hard copies of the SPCs and the PLs, which are in accordance with the marketing authorisation, are conclusive.

Search with the first character of the name of the medicinal product: n


Summaries of Product Characteristics 1 - 30 of 211
  1  2  3  4  5  6  7  8  |  Next 30   >    
Package
leaflet
Status for
supply
Name of the medicinal product

European Medicines Agency's website:
Naglazyme - EMA: EPAR PI
Finnish Swedish

PL

Resepti

Naldix 50 mg tabletti, kalvopäällysteinen SPC 2022-02-04

PL

Resepti

Nalgesin 220 mg tabletti, kalvopäällysteinen SPC 2022-02-14

PL

Resepti

Naloxon B. Braun 0.4 mg-ml injektio-infuusioneste, liuos SPC 2019-09-26

PL

Resepti

Naltrexon Accord 50 mg tabletti, kalvopäällysteinen SPC 2022-04-25

PL

Resepti

Naltrexon Vitaflo 50 mg tabletti, kalvopäällysteinen SPC 2022-03-18

PL

Resepti

Naltrexone POA Pharma 50 mg tabletti, kalvopäällysteinen SPC 2022-02-04

European Medicines Agency's website:
Namuscla - EMA: EPAR PI
Finnish Swedish

PL

Resepti

Nanogam 100 mg-ml infuusioneste, liuos SPC 2021-12-17

PL

Resepti

Nanogam 50 mg-ml infuusioneste, liuos SPC 2021-12-17

PL

Resepti

Naprometin 500 mg tabletti SPC 2022-04-07

PL

Resepti

Napromex 500 mg tabletti, kalvopäällysteinen SPC 2019-10-16

PL

Resepti

Naproxen Krka 550 mg tabletti, kalvopäällysteinen SPC 2020-05-05

PL

Resepti

Naproxen Mylan 500 mg tabletti SPC 2020-10-16

PL

Resepti

Naproxen Orion 250 mg, 500 mg tabletti SPC 2021-11-04

PL

Resepti

Naramig 2.5 mg tabletti, kalvopäällysteinen SPC 2021-11-29.doc

PL

Resepti

Naratriptan Orifarm 2.5 mg tabletti SPC 2021-12-02

PL

Resepti/itsehoito

Nasacort 55 mikrog-annos nenäsumute, suspensio SPC 2021-10-19

PL

Itsehoito

Nasment 1 mg-ml nenäsumute, liuos SPC 2021-05-13

PL

Itsehoito

Naso-Ratiopharm 0.5 mg-ml, 1 mg-ml nenäsumute, liuos SPC 2021-02-08

PL

Resepti/itsehoito

Nasofan 50 mikrog-annos nenäsumute, suspensio SPC 2021-07-16 Uusi

PL

Itsehoito

Nasolin 0.5 mg-ml, 1 mg-ml nenäsumute, liuos SPC 2021-03-26

PL

Itsehoito

Nasolin 0.5 mg-ml, 1 mg-ml nenäsumute, liuos SPC 2021-03-26

PL

Resepti

Nasonex 50 mikrog-annos nenäsumute, suspensio SPC 2021-04-27

European Medicines Agency's website:
Natpar - EMA: EPAR PI
Finnish Swedish

PL

Itsehoito

Natr. Chlorid. 9 mg-ml nenätipat, liuos SPC 2021-06-07

PL

Resepti

Natrilix 2.5 mg tabletti, kalvopäällysteinen SPC 2021-12-21

PL

Resepti

Natrilix Retard 1.5 mg depottabletti SPC 2021-11-24

PL

Resepti

Natriumbicarbonate Braun 75 mg-ml infuusioneste SPC 2020-01-09

PL

Resepti

Natriumfluoridi Morningside 5 mg-g hammastahna SPC 2022-08-04 Uusi

  1  2  3  4  5  6  7  8  |  Next 30   >